Advertisement
New Zealand markets open in 46 minutes
  • NZX 50

    11,836.04
    -39.31 (-0.33%)
     
  • NZD/USD

    0.5904
    -0.0015 (-0.26%)
     
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • OIL

    82.51
    -0.18 (-0.22%)
     
  • GOLD

    2,394.40
    +6.00 (+0.25%)
     

Could Latecomer Moderna Match Big Pharma Rivals in RSV?

Could Latecomer Moderna Match Big Pharma Rivals in RSV?

Moderna (NASDAQ: MRNA) started its billion-dollar story with the coronavirus vaccine. The company plans to submit its candidate for use in older adults to regulators soon and aims for a 2024 launch. The U.S. Food and Drug Administration (FDA) recently approved GSK's vaccine -- the first RSV vaccine to ever win a nod.